NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

After-hours movers: Viking Therapeutics gains on obesity drug update, United Airlines falls following results

Published 2023-10-17, 05:40 p/m
© Reuters.
MSFT
-
UAL
-
JBHT
-
RARE
-
VKTX
-

After-Hours Stock Movers:

Viking Therapeutics, Inc. (NASDAQ:VKTX) 6% HIGHER; announced that new results from the company's Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial of VK2735 were featured in an oral presentation at ObesityWeek 2023, the annual meeting of The Obesity Society. VK2735 is a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors in development for the potential treatment of various metabolic disorders such as obesity.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) 5% LOWER; announced that it has commenced an underwritten public offering of up to $300,000,000 of shares of its common stock

United Airlines Holdings Inc (NASDAQ:UAL4% LOWER; reported Q3 EPS of $3.65, $0.24 better than the analyst estimate of $3.41. Revenue for the quarter came in at $14.48 billion versus the consensus estimate of $14.43 billion.

JB Hunt Transport Services Inc (NASDAQ:JBHT3% LOWER; reported Q3 EPS of $1.80, $0.05 worse than the analyst estimate of $1.85. Revenue for the quarter came in at $3.16 billion versus the consensus estimate of $3.18 billion.

Microsoft (NASDAQ:MSFT) 1% HIGHER; is expected to bring on Amazon (NASDAQ:AMZN) as a customer for its 365 cloud productivity tools, Insider reported.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.